Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Extensive Stage Small Cell Lung Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)UnknownNCT05901584
What this trial is testing

Cadonilimab (AK104) With or Without CT as 2rd Line Treatment for ES-SCLC

Who this might be right for
ImmunotherapySecond-line Treatment
Second Affiliated Hospital of Zunyi Medical University 30
Testing effectiveness (Phase 2)Looking for participantsNCT07803848
What this trial is testing

Study to Confirm Efficacy and Feasibility of Tarlatamab Treatment in Patients With Extensive Stage Small-cell Lung Cancer With Poor Performance Status

Who this might be right for
Small-cell Lung Cancer
AIO-Studien-gGmbH 57
Not applicableUnknownNCT04731909
What this trial is testing

Toripalimab Combined With Anlotinib, Etoposide and Platinum in the Treatment of Extensive-stage Small Cell Lung Cancer

Who this might be right for
SCLC, Extensive StageLung CancerSmall Cell Lung Cancer
Third Military Medical University 80
Testing effectiveness (Phase 2)UnknownNCT02972320
What this trial is testing

Extensive Stage Sclc Patients Who Were Benefit From First-line Treatment Accept Temozolomide Maintain Therapeutic

Who this might be right for
Extensive Stage Small Cell Lung Cancer
Yunpeng Liu 60
Testing effectiveness (Phase 2)Study completedNCT05509699
What this trial is testing

Surufatinib Plus Anti-PD-1/L1 as Maintenance Therapy in Extensive-Stage Small Cell Lung Cancer

Who this might be right for
Extensive-Stage Small Cell Lung Cancer
Hutchison Medipharma Limited 21
Testing effectiveness (Phase 2)Active Not RecruitingNCT05092412
What this trial is testing

Low-dose Radiotherapy Combined With Durvalumab, Chemotherapy(EP) in the Treatment of ES-SCLC

Who this might be right for
Lung CancerExtensive-stage Small-cell Lung CancerDurvalumab
You Lu 30
Testing effectiveness (Phase 2)Looking for participantsNCT06110572
What this trial is testing

Phase I/II Trial in ES-SCLC to Enhance Response to Atezolizumab Plus Chemotherapy With Total Body Irradiation

Who this might be right for
Extensive Stage Lung Small Cell CarcinomaStage IV Lung Cancer
Vanderbilt-Ingram Cancer Center 18
Testing effectiveness (Phase 2)UnknownNCT04562337
What this trial is testing

SHR-1316 Combined With Chemotherapy and Chest Radiotherapy in ES-SCLC

Who this might be right for
Extensive-stage Small Cell Lung Cancer
Shandong Cancer Hospital and Institute 67
Early research (Phase 1)Study completedNCT00020579
What this trial is testing

MS-275 in Treating Patients With Advanced Solid Tumors or Lymphoma

Who this might be right for
Cancer
National Institutes of Health Clinical Center (CC) 75
Not applicableUnknownNCT00693836
What this trial is testing

Studying Patterns, Causes, and Control of Disease in Patients With Lung Cancer in the North Trent (England) Region

Who this might be right for
Lung Cancer
Cancer Research Centre at Weston Park Hospital 2,000
Not applicableLooking for participantsNCT07636200
What this trial is testing

The EASE Study: Randomized Trial of a Novel Approach to Addressing Fear of Progression in Advanced Cancer

Who this might be right for
Advanced Solid Tumor CancerStage IV Cancer (Solid Tumors Only)Glioblastoma+2 more
University of Colorado, Boulder 250
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07141771
What this trial is testing

An Umbrella Study of Recurrent, Extensive Stage Small Cell Lung Cancer Based on Molecular Typing

Who this might be right for
SCLC, Extensive Stage
Cancer Institute and Hospital, Chinese Academy of Medical Sciences 100
Not applicableStudy completedNCT07489339
What this trial is testing

MDT-Based Nursing for Small Cell Lung Cancer During Chemo-Immunotherapy

Who this might be right for
Small Cell Lung CancerExtensive-Stage Small Cell Lung CancerLung Neoplasms
Shanxi Province Cancer Hospital 200
Not applicableStudy completedNCT00003329
What this trial is testing

Identification of Genes Associated With Cancer in Patients and Siblings Who Have Cancer

Who this might be right for
Breast CancerColorectal CancerLung Cancer+1 more
Eastern Cooperative Oncology Group 4,000
Testing effectiveness (Phase 2)UnknownNCT02179528
What this trial is testing

Study of Small Doses of Etoposide as Maintenance Treatment in Small Cell Lung Cancer(SCLC)

Who this might be right for
Small Cell Lung Cancer Extensive Stage
Peking University Cancer Hospital & Institute 210
Not applicableStudy completedNCT01999881
What this trial is testing

Impacts of Exercise on Prognostic Biomarkers in Lung Cancer Patients

Who this might be right for
Extensive Stage Small Cell Lung CancerHealthy, no Evidence of DiseaseLimited Stage Small Cell Lung Cancer+9 more
University of Wisconsin, Madison 21
Large-scale testing (Phase 3)Study completedNCT00290953
What this trial is testing

Evaluation of the Overall Survival of Meclinertant Versus Placebo After a First Line Chemotherapy With Cisplatin + Etoposide

Who this might be right for
Lung CancerPulmonary NeoplasmsSmall Cell Lung Cancer
Sanofi 432
Large-scale testing (Phase 3)Ended earlyNCT03033511
What this trial is testing

Rovalpituzumab Tesirine as Maintenance Therapy Following First- Line Platinum-Based Chemotherapy in Participants With Extensive Stage Small Cell Lung Cancer (MERU)

Who this might be right for
Small Cell Lung Cancer
AbbVie 748
Post-approval studies (Phase 4)Study completedNCT05071703
What this trial is testing

Evaluation of TRILACICLIB in Chinese Patients With Extensive-stage Small Cell Lung Cancer (ES-SCLC) for Chemotherapy-induced Myelosuppression, Antitumor Effects of Combination Regimens, and Safety in a Real-world Study

Who this might be right for
Extensive-stage Small-cell Lung Cancer
Jiangsu Simcere Pharmaceutical Co., Ltd. 30
Testing effectiveness (Phase 2)Looking for participantsNCT07057791
What this trial is testing

Phase II Study of Platinum/Etoposide Plus Ivonescimab for Extensive-Stage Small Cell Lung Cancer

Who this might be right for
Extensive Stage Lung Small Cell Cancer
PrECOG, LLC. 60
Next Page